Connect with us

Hi, what are you looking for?

Latest News

Jill Biden gets lesion removed from eyelid, deemed noncancerous

A lesion removed by surgeons last week from first lady Jill Biden’s left eyelid was a noncancerous growth, Dr. Kevin O’Connor, physician to President Joe Biden, said Wednesday.

O’Connor said in a memo released by the White House that a biopsy showed that the legion was seborrheic keratosis, a ‘very common, totally harmless, noncancerous growth.’

Surgeons last week also removed a cancerous lesion above Jill Biden’s right eye and one on her chest. Those lesions were both confirmed to be basal cell carcinoma.

Basal cell carcinoma is the most common type of skin cancer, but also the most curable form. It’s considered highly treatable, especially when caught early. It is a slow-growing cancer that usually is confined to the surface of skin — doctors almost always can remove it all with a shallow incision — and seldom causes serious complications or becomes life-threatening.

‘Dr. Biden is recovering nicely from her procedures,’ O’Connor wrote. ‘She experienced some anticipated mild bruising and swelling, but feels very well.’

This post appeared first on FOX NEWS

You May Also Like

Economy

Mimiq, Inc is announcing today the launch of their new product, Mimiq Track, at CES as part of their latest product line to operate...

Investing

Genesis Trading, the cryptocurrency brokerage and lender that halted customer withdrawals in the aftermath of FTX collapse, believes it can sort out its financial...

Editor's Pick

If you haven’t been following the “Twitter Files” saga, the gist of it is that the US federal government routinely pressured pre-Musk Twitter, and...

Editor's Pick

On April 23, 1985, the Coca-Cola Company made one of the biggest mistakes in American business history: it changed the formula for Coca-Cola. Outraged...



Disclaimer: Questofprogress.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2023 Questofprogress.com